Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(1):129–48. https://doi.org/10.1002/ajh.26352.
2. Simon HU, Rothenberg ME, Bochner BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol. 2010;126(1):45–9. https://doi.org/10.1016/j.jaci.2010.03.042.
3. Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130(3):607-612.e9. https://doi.org/10.1016/j.jaci.2012.02.019.
4. Bagot M, Bodemer C, Wechsler J, et al. Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome. Ann Dermatol Venereol. 1990;117(11):883–5. https://europepmc.org/article/med/2099714. Accessed 16 Sept 2021
5. Roufosse F, Cogan E, Goldman M. Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):389–413. https://doi.org/10.1016/j.iac.2007.07.002.